Thailand to cost opposition chief over ‘royal vaccine’ remarks


Thailand will cost the nation’s main opposition determine beneath its harsh lèse majesté legislation after he accused an organization owned by King Maha Vajiralongkorn of searching for to revenue from distributing the Oxford/AstraZeneca coronavirus vaccine.

The transfer in opposition to Thanathorn Juangroongruangkit comes as Prime Minister Prayuth Chan-ocha’s authorities makes an attempt to silence criticism of Thailand’s billionaire monarch by opening circumstances beneath the legislation, which carries a most 15-year jail time period, in opposition to dozens of supporters of a six-month-old democracy motion.

Thailand’s digital affairs ministry stated on Wednesday that the federal government had additionally requested police to cost Mr Thanathorn, who has confronted a number of prison prices since entering politics in 2018, beneath the “computer-related crimes” act.

In an interview with the Monetary Occasions, Mr Thanathorn, chief of the Progressive Motion, stated that giving Siam Bioscience unique rights to distribute the Oxford/AstraZeneca vaccine was “an try to shore up the recognition of the monarchy” and that “the vaccine was not given by the king”.

The Thai firm is 100 per cent owned by the Crown Property Bureau, which manages the king’s wealth portfolio, estimated to be worth in excess of $40bn. The politician first aired the accusations in a Fb Reside presentation on Monday about what he referred to as the “royal vaccine”.

 “The Prayuth authorities pays for the vaccine utilizing taxpayer cash,” Mr Thanathorn instructed the FT earlier than information emerged that he can be charged.

A authorities spokesman referred the FT to remarks by Anutin Charnvirakul, Thailand’s well being minister and deputy prime minister, who rejected Mr Thanathorn’s criticism, saying: “Vaccines are an necessary situation on this emergency state of affairs, and shouldn’t be made a political situation.” 

Thailand in November introduced a cope with AstraZeneca to license and produce 26m doses of the drugmaker’s vaccine, which it goals to distribute by mid-year. The federal government has stated it might supply 61m doses of the vaccine in all. 

Below a separate settlement with the drugmaker, Siam Bioscience will produce as much as 200m doses of the vaccine, most of which might be exported. Nakorn Premsri, Thailand’s vaccine chief, instructed the FT final month that native vaccine manufacturing capability was a matter of “nationwide safety”.

Mr Thanathorn stated that whereas Siam Bioscience was a newcomer to the vaccine business, “it’s now changing into the largest participant” in Thailand. 

Siam Bioscience declined a request for remark. Mr Thanathorn didn’t accuse AstraZeneca of any wrongdoing.

Final 12 months, the constitutional courtroom dissolved Mr Thanathorn’s former social gathering, Future Forward, which got here in third within the 2019 election. The choice angered supporters and helped spark the protests. 

Final 12 months its MPs, who regrouped in parliament beneath the identify Transfer Ahead, probed taxpayer spending on the king and his royal workplace, together with a fleet of 38 aircraft reserved for royal use. 

The Thai king’s energy and wealth have turn into the main target of unprecedented scorn by contributors within the protest movement, which started final July. 

Whereas Thai authorities had beforehand avoided utilizing the lèse majesté legislation lately, they’ve opened circumstances in opposition to greater than 50 individuals since November. A Thai courtroom on Tuesday handed Anchan Preelert, a former civil servant, a sentence of more than 43 years for sharing antimonarchist posts, in what human rights teams described as a warning to protesters to curb criticisms of the king.

After efficiently reining in native Covid-19 infections final 12 months, Thailand is attempting to comprise a new wave of infections that has elevated public strain on the federal government to roll out vaccines extra shortly. 

Twitter: @JohnReedwrites


Please enter your comment!
Please enter your name here